CTOs on the Move

GenMark Diagnostics

www.genmarkdx.com

 
In 1993, a novel technology was invented by a team that included Jon Faiz Kayyem, PhD at The California Institute of Technology (CalTech). This invention combined nucleic acids and microelectronics to produce an electronic sensor for DNA detection. His invention was based on electrical detection of nucleic acids on a cassette based detection platform. Dr. Kayyem went on to found Clinical Micro Sensors, with the goal of translating this “eSensor” technology to disposable chips. Following several acquisitions of the technology, Dr. Kayyem became actively involved again in 2009, returning as an investor and then as CEO and Chairman of the ...
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.genmarkdx.com
  • 5964 La Place Court Suite 100
    Carlsbad, CA USA 92008
  • Phone: 760.448.4300

Executives

Name Title Contact Details

Similar Companies

CarePro Health Services

CarePro Health Services is a Cedar Rapids, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Advacare Home Services

Advacare Home Services is a Bridgeville, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DKBmed

DKBmed is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Osiris Therapeutics

Osiris Therapeutics, Inc. is a leading stem cell company focused on developing and marketing products to treat medical conditions in the inflammatory, autoimmune, orthopedic and cardiovascular areas. Osiris’ stem cell products have significant therapeutic potential because of their ability to regulate inflammation, promote tissue regeneration and prevent pathological scar formation. In Biosurgery, we harness the ability of cells and novel constructs to promote the body`s natural healing. The goals are to improve surgical outcomes and offer better treatment options for patients and physicians. We like a challenge, so the focus is in areas where we believe we can have a significant impact. Difficult indications and challenging cases are targeted. Osiris has been studying tissue engineering since the beginning, and its dedicated team conducted groundbreaking research in the field. The work in bone led to the development of the successful product Osteocel, now owned by NuVasive Inc. Now, application of these technologies is being expanded beyond bone, to soft tissues, such as cartilage and tendon, and also wound healing.

Sciton, Inc

Sciton, Inc is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.